Karin Leinar Boll

Karin Leinar Boll is an accomplished professional in the field of drug safety and medical affairs, currently serving as the Director of Global Drug Safety at Immedica Pharma AB since May 2024. Prior to this role, Karin held key positions including Global Patient Safety Operations and M&A Lead at Karo Healthcare from October 2020 to May 2024, and various roles at Merck Group from October 2011 to October 2020, eventually becoming SSC Manager Nordic-Baltic. Karin's experience also includes acting as the Head of Medical Affairs and EU Qualified Person for Pharmacovigilance at BioPhausia AB, and serving as a Medical Information and Safety Officer at Wyeth AB. Educational qualifications include a Master of Science in Biomedicine from Karolinska Institutet and additional studies in Economics at Stockholm University.